53234-67-6Relevant articles and documents
Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold
Kawai, Junya,Ota, Masahiro,Ohki, Hitoshi,Toki, Tadashi,Suzuki, Makoto,Shimada, Takashi,Matsui, Satoshi,Inoue, Hidekazu,Sugihara, Chika,Matsuhashi, Norikazu,Matsui, Yumi,Takaishi, Sachiko,Nakayama, Kiyoshi
, p. 893 - 898 (2019)
Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) plays a key role in one-carbon (1C) metabolism in human mitochondria, and its high expression correlates with poor survival of patients with various types of cancer. An isozyme-selective MTHFD2 inhibitor is highly attractive for potential use in cancer treatment. Herein, we disclose a novel isozyme-selective MTHFD2 inhibitor DS44960156, with a tricyclic coumarin scaffold, which was initially discovered via high-throughput screening (HTS) and improved using structure-based drug design (SBDD). DS44960156 would offer a good starting point for further optimization based on the following features: (1) unprecedented selectivity (>18-fold) for MTHFD2 over MTHFD1, (2) a molecular weight of less than 400, and (3) good ligand efficiency (LE).
Synthesis of 3-azabicyclo[3.3.1]Nonane-6,9-diones
Williams, Brian D.,Williams, Birute,Bernardoni, Francis,Finn, Robert C.,Zubieta, Jon
, p. 2199 - 2206 (2007/10/03)
A one pot synthesis of 3-azabicyclo[3.3.1]nonane-6,9-diones is described via the additibn of acryloyl chloride to enamines of N-carboxy-4 piperidones. Yields of bicycle were highest when additions were made to vigorously boiling solutions of morpholine en